Moloney Securities Asset Management’s GSK GSK Stock Holding History

Moloney Securities Asset Management’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$1.72M	Sell	39,843 -5,018	-11%	-$196K	0.2%	117
2025 Q2	$1.72M	Buy	44,861 +182	+0.4%	+$6.95K	0.21%	114
2025 Q1	$1.73M	Buy	+44,679	New	+$1.64M	0.23%	105
2020 Q2	–	Sell	-4,248	Closed	-$201K	–	311
2020 Q1	$201K	Sell	4,248 -2,618	-38%	-$140K	0.07%	249
2019 Q4	$403K	Buy	6,866 +2,125	+45%	+$118K	0.12%	202
2019 Q3	$253K	Sell	4,741 -441	-9%	-$22.7K	0.08%	260
2019 Q2	$259K	Sell	5,182 -193	-4%	-$9.68K	0.09%	238
2019 Q1	$281K	Sell	5,375 -17,479	-76%	-$873K	0.1%	229
2018 Q4	$1.09M	Buy	22,854 +1,011	+5%	+$49.8K	0.45%	63
2018 Q3	$1.1M	Sell	21,843 -2,836	-11%	-$144K	0.38%	82
2018 Q2	$1.24M	Buy	24,679 +357	+1%	+$18K	0.47%	59
2018 Q1	$1.19M	Sell	24,322 -446	-2%	-$20.8K	0.48%	57
2017 Q4	$1.1M	Buy	24,768 +3,241	+15%	+$150K	0.46%	66
2017 Q3	$1.09M	Sell	21,527 -293	-1%	-$14.9K	0.49%	56
2017 Q2	$1.18M	Buy	21,820 +714	+3%	+$38.1K	0.59%	46
2017 Q1	$1.11M	Buy	21,106 +3,259	+18%	+$165K	0.58%	44
2016 Q4	$859K	Buy	+17,847	New	+$882K	0.52%	50

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Moloney Securities Asset Management's GSK Position: Q3 2025 in Review

Moloney Securities Asset Management reduced its GSK (GSK) stake by 11% in Q3 2025, selling an estimated $196K and leaving 39,843 shares worth $1.72M. The position accounts for 0.2% of the portfolio, ranked #117.

Moloney Securities Asset Management first reported a position in GSK in Q4 2016 and has held it in 17 quarters since. The position peaked at $1.73M in Q1 2025. 895 funds tracked by Wall St. Rank hold GSK as of Q3 2025.

Moloney Securities Asset Management held 39,843 shares of GSK worth $1.72M as of Q3 2025.
Moloney Securities Asset Management sold 5,018 GSK shares in Q3 2025, an estimated $196K.
GSK made up 0.2% of Moloney Securities Asset Management's portfolio in Q3 2025, its #117 holding.
Moloney Securities Asset Management first reported a position in GSK in Q4 2016 and has held it in 17 quarters since.
Moloney Securities Asset Management's GSK position peaked at $1.73M in Q1 2025.
895 funds tracked by Wall St. Rank held GSK as of Q3 2025.

Based on Moloney Securities Asset Management's 13F filing for Q3 2025, filed 5 Nov 2025.